Fluid retention is the most common modifiable risk factor for mortality and cardiovascular events in volume overloaded patients1. Fluid retention leads to poorly controlled hypertension, cardiac dysfunction and pulmonary edema, and has been associated with excess mortality in this population. The clinical estimation of a patient's volume status by combining the patient's symptoms, blood pressure, and weight changes represent a clinical assessment that is prone to imprecision2. This article proposes a protocol that utilizes bedside ultrasound (US) techniques to guide the effective management of pulmonary edema. Chest and inferior vena cava (IVC) US form the cornerstone of this proposed clinical protocol for fluid removal. Both Chest and IVC US have a long track record in the literature for a spectrum of applications including the management of acute respiratory failure, end-stage renal disease (ESRD), and circulatory shock.
Chest US has been shown to provide objective data for the assessment of pulmonary edema in ESRD patients, and accurately reflects the decreasing severity of pulmonary edema as dialysis goes on3. Similarly, US of the inferior vena cava (IVC) has long been utilized for various clinical applications. IVC US is recommend as a routine component of transthoracic echocardiographic examination and serves several purposes, including for the estimation of right atrial pressure (RAP) that is a mark of volume status and pre- load to the heart4. Several studies have elucidated a correlation between IVC caliber and fluid responsivity in shock states5,6. Also notable in the management of shock states, chest ultrasound has been used to detect the onset of new pulmonary edema during fluid resuscitation in circulatory shock, commonly by way of a bedside US application referred to as the Fluid Administration Limited by Lung Sonography (FALLS) protocol7,8. The protocol proposed here, named the Reverse-FALLS protocol, combines well-documented features of chest and IVC ultrasound for the safe and effective management of pulmonary edema.
Portable, or bedside, US is an imaging modality that offers immediate and reliable data that reduces exposure to radiation, eliminates the need for patient transport, and reduces resource utilization. Due to its availability and the essential absence of associated adverse effects, bedside US can be repeated to monitor and tailor diuretic therapy. Finally, bedside US is easy for clinicians to perform and interpret in real-time9.
Chest US is a widely-accepted technique that detects specific artifact patterns that represent various pleural and parenchymal pathologies. For instance, "A-lines" are horizontal hyperechoic (bright) reverberation artifacts of the pleural surface and they indicate normal parenchyma that is free of fluid. Alternatively, "B-lines" are hyperechoic vertical artifacts that begin at the inferior aspect of the pleural line and extend to the end of the screen, moving synchronously with respiration. The presence of B-lines in the setting of suspected volume overload indicates extravascular lung water. These B-lines characteristically dissipate during diuresis in a manner that corresponds to volume removal leading to the re-emergence of the dry A-line artifact pattern3. Studies indicate that these US findings are closely associated with elevated pulmonary filling pressures, as assessed by invasive methods10.
US may also be used to measure the IVC vessel diameter and collapsibility index, which is the percentage of diameter reduction during spontaneous breathing. Several studies have shown a correlation between IVC measurements and volume changes during diuresis, demonstrating the feasibility and applicability of this tool for patients with pulmonary edema11.
Here, we propose a sample US protocol, the Reverse-FALLS protocol, which integrates both lung and IVC US to guide fluid removal therapy in patients with pulmonary edema.